Biblio Discovery — Demo Discovery Service

11 hasil untuk "Dagher, Chebly"

Menampilkan 1–11 · 0,34 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Level 3 Cardiopulmonary Exercise Testing to Guide Therapeutic Decisions in Non-Severe Pulmonary Hypertension with Lung Disease

    Parikh, Raj; Dagher, Chebly; Farber, Harrison W.

    Life (Basel) · 2025 · Inggris · PubMed Central

    Inhaled treprostinil is approved for the treatment of pulmonary hypertension-associated interstitial lung disease (PH-ILD); however, it has not shown significant benefit in patients with a pulmonary vascular resistance (PVR) < 4 WU. As such, treatment for non-severe PH-ILD remains controversial. A…

  2. Artikel Jurnal Teks lengkap

    The Impact of Glycemic Control on Ranibizumab Efficacy in Diabetic Retinopathy: A Retrospective Analysis

    Dagher, Chebly; Akiki, Maria; Saliby, Rita dkk.

    Cureus · 2025 · Inggris · PubMed Central

    Background: Diabetic retinopathy (DR), a leading cause of vision loss, is driven by inflammation, oxidative stress, and vascular endothelial growth factor (VEGF) production, with elevated blood glucose and advanced glycation end products (AGEs) exacerbating retinal damage. While intravitreal VEGF…

  3. Artikel Jurnal Teks lengkap

    Comparison of Infection Risks Between Intravenous and Subcutaneous Treprostinil in Patients with Pulmonary Hypertension

    Akiki, Maria; Dagher, Chebly; Swanson, Kristen dkk.

    Antimicrob Steward Healthc Epidemiol · 2025 · Inggris · PubMed Central

    Background: Treprostinil, a prostacyclin analog, is used to manage pulmonary hypertension (PH) through continuous intravenous (IV) infusion via a central venous catheter (CVC) or continuous subcutaneous (SC) infusion via a small infusion pump connected to a catheter. This study compares the…

  4. Artikel Jurnal Teks lengkap

    P-2147. Predicting Infection-Related Mortality in Breast Cancer: A Nomogram-Based Risk Stratification Approach

    Akiki, Maria; Hallit, Rabih; Dagher, Chebly dkk.

    Open Forum Infect Dis · 2026 · Inggris · PubMed Central

    BACKGROUND: Infections are a major cause of illness and death in breast cancer patients. As survival improves, infection risk remains high despite being preventable. This study aims to identify key clinical and demographic factors associated with infectious disease mortality in breast cancer…

  5. Artikel Jurnal Teks lengkap

    P-2036. A Quality Improvement Project to Increase Pneumococcal Vaccination Rates in a Primary Care Clinic

    Akiki, Maria; Dagher, Chebly; Falcetti, Tera dkk.

    Open Forum Infect Dis · 2026 · Inggris · PubMed Central

    BACKGROUND: Despite established national guidelines, pneumococcal vaccination rates in primary care remain low. Contributing factors include limited time during outpatient visits, competing clinical demands, lack of integrated reminders, and provider uncertainty due to frequent updates in vaccine…

  6. Artikel Jurnal Teks lengkap

    Semaglutide-Induced Acute Pancreatitis Leading to Death After Four Years of Use

    Dagher, Chebly; Jailani, Mohamed; Akiki, Maria dkk.

    Cureus · 2024 · Inggris · PubMed Central

    Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are essential in managing type 2 diabetes mellitus, promoting glucose regulation, weight reduction, and cardiovascular protection. Here, we report a unique case of semaglutide-induced pancreatitis complicated by distributive shock and death after…

  7. Artikel Jurnal Teks lengkap

    Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype

    Dagher, Chebly; Thomas, Allysse; Al Absi, Suzie dkk.

    Adv Respir Med · 2026 · Inggris · PubMed Central

    HIGHLIGHTS: What are the main findings? Rapid inpatient uptitration of inhaled treprostinil allowed all six severe PH-ILD patients to reach therapeutic dosing within one week. The protocol was well tolerated and associated with early hemodynamic improvement without dose interruptions or 90-day…

  8. Artikel Jurnal Teks lengkap

    Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease

    Dagher, Chebly; Akiki, Maria; Swanson, Kristen dkk.

    Life (Basel) · 2025 · Inggris · PubMed Central

    Patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) and concomitant interstitial lung disease (ILD) are particularly challenging to manage due to concerns about ventilation–perfusion mismatch with systemic vasodilators. In this case series, we evaluated the…

  9. Artikel Jurnal Teks lengkap

    Sotatercept for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease: Efficacy and Safety Insights

    Dagher, Chebly; Akiki, Maria; Swanson, Kristin dkk.

    J Clin Med · 2025 · Inggris · PubMed Central

    Background/Objectives: Sotatercept has demonstrated efficacy in pulmonary arterial hypertension (PAH), but its use has not been studied in patients with Group 3 pulmonary hypertension (PH). Additionally, patients with connective tissue disease-associated PAH (CTD-PAH) were underrepresented in the…

  10. Artikel Jurnal Teks lengkap

    Use of Sotatercept to Facilitate Transition From Intravenous to Oral Prostacyclin Therapy

    Dagher, Chebly; Akiki, Maria; Swanson, Kristen dkk.

    Clin Respir J · 2025 · Inggris · PubMed Central

    Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance (PVR) leading to right ventricular failure and high mortality. Parenteral prostacyclin therapy remains the cornerstone for high‐risk patients but is limited by complications and…

  11. Artikel Jurnal Teks lengkap

    Development of a Tool to Assess the Severity of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Guide to Assist Therapeutic Choices

    Fiscus, Garrett; Dagher, Chebly; O’Sullivan, David dkk.

    Adv Respir Med · 2025 · Inggris · PubMed Central

    HIGHLIGHTS: What are the main findings? We created such a scoring tool to guide PH-specific therapy in PH-ILD patients using subjective and objective information (WHO FC, CI, TAPSE, PVR). A score of 3 or greater in the PH-ILD Severity score yielded an AUC of 0.831 for the composite endpoint of…